# A Study in Participants With Diabetic Peripheral Neuropathic Pain in China

> **NCT01179672** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 405 (actual)

## Conditions studied

- Diabetic Neuropathy, Painful

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01179672
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2014-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179672, "A Study in Participants With Diabetic Peripheral Neuropathic Pain in China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01179672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*